# OnKure Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jan 21, 2025

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: SCHEDULE 13D/A
- Filed: 2025-01-21
- Accepted by EDGAR: Jan 21, 2025, 18:38 ET
- Period: not reported
- Accession: 0001104659-25-004963
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000110465925004963/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000110465925004963/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000110465925004963/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-004963. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.